ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC

dc.contributor.authorWu, Y.
dc.contributor.authorCho, B. C.
dc.contributor.authorZhou, Q.
dc.contributor.authorChang, G.
dc.contributor.authorJiang, L.
dc.contributor.authorMetro, G.
dc.contributor.authorMartin, C.
dc.contributor.authorDe Castro, G.
dc.contributor.authorVansteenkiste, J.
dc.contributor.authorVicente, D.
dc.contributor.authorMilner, A.
dc.contributor.authorRigas, J.
dc.contributor.authorChen, Y.
dc.contributor.authorProvencio, M.
dc.contributor.authoraffiliation[Wu, Y.] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
dc.contributor.authoraffiliation[Zhou, Q.] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
dc.contributor.authoraffiliation[Wu, Y.] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
dc.contributor.authoraffiliation[Zhou, Q.] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
dc.contributor.authoraffiliation[Cho, B. C.] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
dc.contributor.authoraffiliation[Chang, G.] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan
dc.contributor.authoraffiliation[Jiang, L.] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
dc.contributor.authoraffiliation[Metro, G.] Santa Maria Della Misericordia Hosp, Perugia, Italy
dc.contributor.authoraffiliation[Martin, C.] Inst Alexander Fleming, Dept Clin Oncol, Buenos Aires, DF, Argentina
dc.contributor.authoraffiliation[De Castro, G.] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
dc.contributor.authoraffiliation[Vansteenkiste, J.] Univ Hosp KU Leuven, Leuven, Belgium
dc.contributor.authoraffiliation[Vicente, D.] HUV Macarena, Seville, Spain
dc.contributor.authoraffiliation[Milner, A.] Astrazeneca, Biometr & Informat Sci, Cambridge, England
dc.contributor.authoraffiliation[Rigas, J.] Astrazeneca, Gma Oncol Ta, Gaithersburg, MD USA
dc.contributor.authoraffiliation[Chen, Y.] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan
dc.contributor.authoraffiliation[Provencio, M.] Hosp Puerta Hierro, Med Oncol, Madrid, Spain
dc.date.accessioned2025-01-07T16:06:36Z
dc.date.available2025-01-07T16:06:36Z
dc.date.issued2018-10-01
dc.identifier.doi10.1016/j.jtho.2018.08.324
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418312826/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27627
dc.identifier.wosID454014500305
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS358-S359
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.titleASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files